Cancer drugs’ share of new FDA approvals doubled this decade thanks to smarter Research and Development
January 07, 2020 Why the surge in oncology successes? Because pharmaceutical companies have taken a new approach to drug development, focusing on pursuing novel mechanisms for treating cancer and validating them with clinical trials that are much better designed than they were in the past. Couple that with an FDA that has doubled down on … Read more